{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:51:57Z","timestamp":1777002717009,"version":"3.51.4"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Abdominal aortic aneurysm (AAA) is often fatal when ruptured, and current guidelines suggest surgical management at suprathreshold sizes (50 mm for women or 55 mm for men) or with rapid expansion (&amp;gt;5 mm\/year). Many medical therapies have been assessed for reducing subthreshold AAA expansion, though the evidence remains inconclusive. This network meta-analysis (NMA) compares AAA growth and mortality amongst medical treatments for AAAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE (via PubMed), Scopus, Web of Science, EBSCO, and Cochrane Library databases were searched for relevant randomized controlled trials (RCTs) from database inception to 2024. Outcomes assessed included AAA growth rate, rate of referral for aneurysm surgery, overall mortality, and discontinuation from adverse effects. Data were analysed using R software, and P-score were used to rank different treatments. The GRADE framework was performed to assess the quality of evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen RCTs comprising 3084 patients were included in this NMA. Abdominal aortic aneurysm diameters ranged from 3.1 to 4.6 cm in the intervention group and 3.5-4.5 cm in the placebo group. Study-level mean annual growth rate ranged from 1.2 to 2.8 mm\/year in the intervention group compared with placebo (1.2-2.6 mm\/year). There were no significant differences in AAA growth among the compared groups (P-score probability in brackets): propranolol (0.73), telmisartan (0.66), antibiotics (0.53), placebo (0.53), ACE inhibitors (0.52), ticagrelor (0.46), and pemirolast (0.06). There were no significant differences among the compared groups in terms of aneurysm surgery referral rates, with propranolol (0.91), antibiotics (0.56), placebo (0.45), and pemirolast (0.08) showing similar outcomes. Similarly, no significant differences were observed in overall mortality rates across the groups, including telmisartan (0.87), antibiotics (0.57), ACE inhibitors (0.51), placebo (0.35), and propranolol (0.17). However, propranolol (OR\u2009=\u20093.14, 95% CI, 1.34-7.35) and ticagrelor (OR\u2009=\u20095.10, 95% CI, 1.12-23.18) were associated with a higher rate of discontinuation due to adverse events. Most of the studies analysed demonstrated moderate quality evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current evidence highlights ongoing uncertainty regarding the efficacy of medical therapies in reducing subthreshold AAA growth rates, rates of referral for surgical repair, or overall mortality. The absence of statistically significant benefit may reflect underpowered datasets rather than definitive treatment inefficacy. Future large-scale, appropriately powered RCTs evaluating emerging medical treatments are required to accurately assess their clinical potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/icvts\/ivag088","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:36:35Z","timestamp":1774096595000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Medical Therapies for Subthreshold Abdominal Aortic Aneurysm Growth and Mortality: A Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-4462","authenticated-orcid":false,"given":"Phil Yi Jun","family":"Lu","sequence":"first","affiliation":[{"name":"Frankston Hospital, Peninsula Health Vascular Surgery Unit, Department of Surgery, , Melbourne, VIC 3199,","place":["Australia"]},{"name":"Alfred Health Vascular Surgery, Department of Surgery, , Melbourne, VIC 3004,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-8925","authenticated-orcid":false,"given":"Ishith","family":"Seth","sequence":"additional","affiliation":[{"name":"Frankston Hospital, Peninsula Health Plastic Surgery Unit, Department of Surgery, , Melbourne, VIC 3199,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey Hiu Ching","family":"Fung","sequence":"additional","affiliation":[{"name":"Austin Health Cardiothoracic Surgery, , Melbourne, VIC 3084,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Varcoe","sequence":"additional","affiliation":[{"name":"Prince of Wales Hospital Vascular Surgery, , Sydney, NSW 2031,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Rozen","sequence":"additional","affiliation":[{"name":"Frankston Hospital, Peninsula Health Plastic Surgery Unit, Department of Surgery, , Melbourne, VIC 3199,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Surgery, Port Macquarie Base Hospital , Port Macquarie, NSW 2444,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026042323261522000_ivag088-B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gheart.2013.12.010","article-title":"Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"2026042323261522000_ivag088-B2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2010.09.011","article-title":"Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery","volume":"41 (Suppl. 1)","author":"Moll","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026042323261522000_ivag088-B3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1586\/14779072.2015.1074861","article-title":"Understanding the pathogenesis of abdominal aortic aneurysms","volume":"13","author":"Kuivaniemi","year":"2015","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"2026042323261522000_ivag088-B4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3238\/arztebl.2017.0391","article-title":"Incidence, treatment and mortality in patients with abdominal aortic aneurysms","volume":"114","author":"K\u00fchnl","year":"2017","journal-title":"Dtsch Arztebl Int."},{"key":"2026042323261522000_ivag088-B5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"Editor\u2019s choice\u2014European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"67","author":"Wanhainen","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026042323261522000_ivag088-B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jvs.2017.10.044","article-title":"The society for vascular surgery practice guidelines on the care of patients with an abdominal aortic aneurysm","volume":"67","author":"Chaikof","year":"2018","journal-title":"J Vasc Surg."},{"key":"2026042323261522000_ivag088-B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"2026042323261522000_ivag088-B8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jvs.2009.10.113","article-title":"Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms","volume":"51","author":"Ouriel","year":"2010","journal-title":"J Vasc Surg"},{"key":"2026042323261522000_ivag088-B9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/bjs.5778","article-title":"Final 12-year follow-up of surgery versus surveillance in the UK small aneurysm trial","volume":"94","author":"Powell","year":"2007","journal-title":"Br J Surg."},{"key":"2026042323261522000_ivag088-B10","doi-asserted-by":"publisher","first-page":"908747","DOI":"10.3389\/fcvm.2022.908747","article-title":"Association between metformin and abdominal aortic aneurysm: a meta-analysis","volume":"9","author":"Niu","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"2026042323261522000_ivag088-B11","doi-asserted-by":"publisher","first-page":"e008657","DOI":"10.1161\/jaha.118.008657","article-title":"Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis","volume":"7","author":"Salata","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"2026042323261522000_ivag088-B12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/bjs.8707","article-title":"Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms","volume":"99","author":"Sweeting","year":"2012","journal-title":"Br J Surg"},{"key":"2026042323261522000_ivag088-B13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res."},{"key":"2026042323261522000_ivag088-B14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med."},{"key":"2026042323261522000_ivag088-B15","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"2026042323261522000_ivag088-B16","author":"R\u00fccker","year":"2018"},{"key":"2026042323261522000_ivag088-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2288-13-35","article-title":"A graphical tool for locating inconsistency in network meta-analyses","volume":"13","author":"Krahn","year":"2013","journal-title":"BMC Med Res Methodol."},{"key":"2026042323261522000_ivag088-B18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol."},{"key":"2026042323261522000_ivag088-B19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2168.2000.01420-23.x","article-title":"Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomized study","volume":"87","author":"Wilmink","year":"2000","journal-title":"British Journal of Surgery"},{"key":"2026042323261522000_ivag088-B20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1067\/mva.2002.121308","article-title":"Propranolol for small abdominal aortic aneurysms: Results of a randomized trial","volume":"35","author":"The Propranolol Aneurysm Trial Investigators","year":"2002","journal-title":"J Vasc Surg"},{"key":"2026042323261522000_ivag088-B21","first-page":"52","article-title":"Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms","volume":"18","author":"Lindholt","year":"1999","journal-title":"Int Angiol."},{"key":"2026042323261522000_ivag088-B22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1177\/1538574409335037","article-title":"Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial","volume":"43","author":"H\u00f8gh","year":"2009","journal-title":"Vasc Endovascular Surg."},{"key":"2026042323261522000_ivag088-B23","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1046\/j.0007-1323.2001.01845.x","article-title":"Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion","volume":"88","author":"Vammen","year":"2001","journal-title":"Br J Surg."},{"key":"2026042323261522000_ivag088-B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jvs.2008.12.048","article-title":"The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms\u2014a prospective randomized double-blind trial","volume":"50","author":"Karlsson","year":"2009","journal-title":"J Vasc Surg."},{"key":"2026042323261522000_ivag088-B25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"JAMA."},{"key":"2026042323261522000_ivag088-B26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1067\/mva.2001.117891","article-title":"Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study","volume":"34","author":"Mosorin","year":"2001","journal-title":"J Vasc Surg."},{"key":"2026042323261522000_ivag088-B27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7326\/0003-4819-159-12-201312170-00007","article-title":"Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial","volume":"159","author":"Meijer","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026042323261522000_ivag088-B28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/bjs.9824","article-title":"Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm","volume":"102","author":"Sillesen","year":"2015","journal-title":"Journal of British Surgery"},{"key":"2026042323261522000_ivag088-B29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/cvr\/cvz133","article-title":"The effect of ticagrelor on growth of small abdominal aortic aneurysms-a randomized controlled trial","volume":"116","author":"Wanhainen","year":"2020","journal-title":"Cardiovasc Res."},{"key":"2026042323261522000_ivag088-B30","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehw257","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)","volume":"37","author":"Bicknell","year":"2016","journal-title":"Eur Heart J"},{"key":"2026042323261522000_ivag088-B31","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1001\/jamacardio.2020.3524","article-title":"Efficacy of telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial","volume":"5","author":"Golledge","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2026042323261522000_ivag088-B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20590","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)","volume":"20","author":"Kiru","year":"2016","journal-title":"Health Technol Assess."},{"key":"2026042323261522000_ivag088-B33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ejvs.2015.08.010","article-title":"Editor\u2019s choice - pharmaceutical management of small abdominal aortic aneurysms: a systematic review of the clinical evidence","volume":"50","author":"Kokje","year":"2015","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"2026042323261522000_ivag088-B34","first-page":"517","article-title":"Medical treatment of small abdominal aortic aneurysm","volume":"53","author":"Assar","year":"2012","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2026042323261522000_ivag088-B35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/joim.12958","article-title":"Lack of an effective drug therapy for abdominal aortic aneurysm","volume":"288","author":"Golledge","year":"2020","journal-title":"J Intern Med."},{"key":"2026042323261522000_ivag088-B36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41569-018-0114-9","article-title":"Abdominal aortic aneurysm: update on pathogenesis and medical treatments","volume":"16","author":"Golledge","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"2026042323261522000_ivag088-B37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/HCO.0b013e328330c2d3","article-title":"Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients\u2019 management","volume":"24","author":"Golledge","year":"2009","journal-title":"Curr Opin Cardiol."},{"key":"2026042323261522000_ivag088-B38","doi-asserted-by":"publisher","first-page":"e009866","DOI":"10.1161\/jaha.118.009866","article-title":"Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME -2 trial","volume":"7","author":"Pinchbeck","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"2026042323261522000_ivag088-B39","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.ajpath.2012.04.015","article-title":"Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model","volume":"181","author":"Krishna","year":"2012","journal-title":"Am J Pathol."},{"key":"2026042323261522000_ivag088-B40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2009.10.027","article-title":"Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm","volume":"210","author":"Golledge","year":"2010","journal-title":"Atherosclerosis."},{"key":"2026042323261522000_ivag088-B41","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jvs.2018.06.194","article-title":"Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population","volume":"69","author":"Itoga","year":"2019","journal-title":"J Vasc Surg."},{"key":"2026042323261522000_ivag088-B42","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/bjs.10587","article-title":"Association between metformin prescription and growth rates of abdominal aortic aneurysms","volume":"104","author":"Golledge","year":"2017","journal-title":"Br J Surg."},{"key":"2026042323261522000_ivag088-B43","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/bjs.9517","article-title":"Statin use and rupture of abdominal aortic aneurysm","volume":"101","author":"Wemmelund","year":"2014","journal-title":"Br J Surg."}],"container-title":["Interdisciplinary CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/icvts\/advance-article-pdf\/doi\/10.1093\/icvts\/ivag088\/67502148\/ivag088.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/41\/4\/ivag088\/67502148\/ivag088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/41\/4\/ivag088\/67502148\/ivag088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:26:26Z","timestamp":1777001186000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/doi\/10.1093\/icvts\/ivag088\/8539926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivag088","relation":{},"ISSN":["2753-670X"],"issn-type":[{"value":"2753-670X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,24]]},"article-number":"ivag088"}}